EDU [New Oriental Education & Technology] CORRESP: (Original Filing)

[March 3, 2011 VIA EDGAR AND FACSIMILE Larry Spirgel, Assistant Director Christine Adams, Senior Staff Accountant Terry French, Accountant Branch Chief Division of Corporation Finance 100 F Street, N.E. Re: New Oriental Education & Technology Inc. (the “Company”) Form 20-F for the Fiscal Year Ended May 31, 2010 (“2010 20-F”) Filed October 14, 2010 File No. 1-32993 Dear Mr. Spirgel,]

By | 2016-02-29T00:00:52+00:00 March 3rd, 2011|Categories: Chinese Stocks, EDU, SEC Original|Tags: , , , , , |0 Comments

EDU [New Oriental Education & Technology] CORRESP: March 3, 2011 VIA EDGAR AND FACSIMILE Larry

[March 3, 2011 VIA EDGAR AND FACSIMILE Larry Spirgel, Assistant Director Christine Adams, Senior Staff Accountant Terry French, Accountant Branch Chief Division of Corporation Finance 100 F Street, N.E. Re: New Oriental Education & Technology Inc. (the “Company”) Form 20-F for the Fiscal Year Ended May 31, 2010 (“2010 20-F”) Filed October 14, 2010 File No. 1-32993 Dear Mr. Spirgel,]

By | 2016-02-29T00:02:30+00:00 March 3rd, 2011|Categories: Chinese Stocks, EDU, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-K: (Original Filing)

[FORM 10-K x For the fiscal year ended December 31, 2010 or ¨ For the transition period from _________ to _____________ 001-34471 China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Common Stock, par value $0.001 per] [EX-10.4 5 ex104.htm ENGAGEMENT LETTER] [CHINA PHARMA HOLDINGS, INC. "Company" "Holder" "Expiration Date" China Pharma Holdings, Inc., a Delaware corporation (the 1. Definitions "Business Day" "Common Stock" "Exercise Price" “Original Issue Date” “New York Courts” “Trading Day” provided “Trading Market” 2. 3. Registration of Transfers 4. 5. 2 (a) Date of Exercise (b) (c) Buy-In] [Loan Agreement Hereby Heung Mei Tsui made a loan of UDS$230,000 to Onny Investment Limited. The term of the loan is from Sept. 27, 2010 to March 26, 2011, with annual interest of 1%. Upon the due date, Onny Investment Limited will return the principal and the interest therefrom. Loaner: Loanee: ONNY INVESTMENT LIMITED (SEAL) Sept.27, 2010 EX-10.18 8 ex1018.htm] [List of Subsidiaries Names Jurisdiction Ownership Onny Investment Limited British Virgin Islands 100% Hainan Helpson Medical & Biotechnology Co., Ltd. The People’s Republic of China 100% EX-21.1 9 ex211.htm LIST OF SUBSIDIARIES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 2, 2011 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Annual Report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b.] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhilin Li EX-32.1 13 ex321.htm] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) EX-32.2 14 ex322.htm]

By | 2016-03-03T19:52:19+00:00 March 3rd, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-K: FORM 10-K x For the fiscal year ended

[FORM 10-K x For the fiscal year ended December 31, 2010 or ¨ For the transition period from _________ to _____________ 001-34471 China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Common Stock, par value $0.001 per] [EX-10.4 5 ex104.htm ENGAGEMENT LETTER] [CHINA PHARMA HOLDINGS, INC. "Company" "Holder" "Expiration Date" China Pharma Holdings, Inc., a Delaware corporation (the 1. Definitions "Business Day" "Common Stock" "Exercise Price" “Original Issue Date” “New York Courts” “Trading Day” provided “Trading Market” 2. 3. Registration of Transfers 4. 5. 2 (a) Date of Exercise (b) (c) Buy-In] [Loan Agreement Hereby Heung Mei Tsui made a loan of UDS$230,000 to Onny Investment Limited. The term of the loan is from Sept. 27, 2010 to March 26, 2011, with annual interest of 1%. Upon the due date, Onny Investment Limited will return the principal and the interest therefrom. Loaner: Loanee: ONNY INVESTMENT LIMITED (SEAL) Sept.27, 2010 EX-10.18 8 ex1018.htm] [List of Subsidiaries Names Jurisdiction Ownership Onny Investment Limited British Virgin Islands 100% Hainan Helpson Medical & Biotechnology Co., Ltd. The People’s Republic of China 100% EX-21.1 9 ex211.htm LIST OF SUBSIDIARIES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 2, 2011 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Annual Report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b.] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhilin Li EX-32.1 13 ex321.htm] [CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) EX-32.2 14 ex322.htm]

By | 2016-03-03T19:53:27+00:00 March 3rd, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

EDU [New Oriental Education & Technology] CORRESP: (Original Filing)

[March3, 2011 VIA EDGAR AND FACSIMILE Larryirgel,sistant Director Christineams, Senior Staff Accountant Terry French, Accountant Branch Chief Division ofrporation Finance 100 F Street, N.E. Re: New Oriental Education& Technology (thempany) Form 20-F for the Fiscal Year Ended May31, 2010 (2010 20-F) Filed October14, 2010 File No.1-32993]

By | 2016-02-14T13:42:22+00:00 March 3rd, 2011|Categories: Chinese Stocks, EDU, SEC Original|Tags: , , , , , |0 Comments

EDU [New Oriental Education & Technology] CORRESP: March3, 2011 VIA EDGAR AND FACSIMILE Larryirgel,sistant Director

[March3, 2011 VIA EDGAR AND FACSIMILE Larryirgel,sistant Director Christineams, Senior Staff Accountant Terry French, Accountant Branch Chief Division ofrporation Finance 100 F Street, N.E. Re: New Oriental Education& Technology (thempany) Form 20-F for the Fiscal Year Ended May31, 2010 (2010 20-F) Filed October14, 2010 File No.1-32993]

By | 2016-02-14T13:43:19+00:00 March 3rd, 2011|Categories: Chinese Stocks, EDU, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)

[March 3, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 Form 10-Q for Quarterly Period Ended December 31, 2009 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated February 17, 2011, regarding the above-referenced]

By | 2016-03-27T21:16:51+00:00 March 3rd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: March 3, 2011 Division of Corporate Finance 100

[March 3, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 Form 10-Q for Quarterly Period Ended December 31, 2009 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated February 17, 2011, regarding the above-referenced]

By | 2016-03-27T21:18:30+00:00 March 3rd, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar